For the first time in more than 25 years, there is a new type of medication available for the treatment of attention deficit-hyperactivity disorder (ADHD) in children, adolescents and even adults.
The drug Strattera (also known as atomoxetine) hit pharmacy shelves in mid-January. It has generated quite a buzz because it is a non-stimulant and it is taken just once a day.
ADHD is the most common behavioral disorder in children. Studies suggest as many as 4 to 6 percent of elementary school-aged have ADHD.
"ADHD is defined by a set of behaviors in children that trained professionals believe occur more frequently and more intensely compared to other children their age," says Dr. Bruno Anthony, a psychologist and Director of the Maryland Center for Attention and Developmental Disorders (MCADD).
"These behaviors include not being able to concentrate well, being easily distracted. These children have a hard time sticking to a task. They are often disorganized and they can be fidgety and overactive," adds Dr. Anthony who is also an associate professor of psychiatry at the University of Maryland School of Medicine.
"Children with ADHD seem like they are always on the go, climbing and running. They intrude on others space, demanding attention and interrupting others frequently," says Dr. Anthony. He continues, "These problems must have been going on for an extended period of time in different settings, like school and home, for a child to be diagnosed with ADHD."
ADHD is highly treatable, though not curable. Most people are familiar with Ritalin as a treatment option. Ritalin is a stimulant, unlike Strattera.
Scientists believe Strattera works by slowing the absorption of the chemical in the brain that controls attention levels. Some children who take this medication experience side effects like upset stomach, decreased appetite, nausea or vomiting, dizziness, tiredness, and mood swings. Many agree that Strattera is a welcome addition to the treatment options for ADHD.
|
Email this Page
Print this Page © 2008 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System, 22 S. Greene
Street, Baltimore, MD 21201. 1.800.492.5538 TDD: 1.800.735.2258
Physician Referral: 1.800.373.4111
